Detection and Tracking of NY-ESO-1-Specific CD8⁺ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient

• Manami Miyai,

  Affiliation Department of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan

  ⨯
• Shingo Eikawa,

  Affiliation Department of Immunology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan

  ⨯
• Akihiro Hosoi,

  Affiliation Department of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan

  ⨯
• Tamaki Iino,

  Affiliation Department of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan

  ⨯
• Hirokazu Matsushita,

  Affiliation Department of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan

  ⨯
• Midori Isobe,

  Affiliation Faculty of Health and Welfare, Kawasaki University of Medical Welfare, Kurashiki, Okayama, Japan

  ⨯
• Akiko Uenaka,

  Affiliation Faculty of Health and Welfare, Kawasaki University of Medical Welfare, Kurashiki, Okayama, Japan

  ⨯
• Heiichiro Udono,

  Affiliation Department of Immunology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan

  ⨯
• Jun Nakajima,

  Affiliation Department of Thoracic Surgery, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan

  ⨯
• Eiichi Nakayama,

  Affiliation Faculty of Health and Welfare, Kawasaki University of Medical Welfare, Kurashiki, Okayama, Japan

  ⨯
• Kazuhiro Kakimi

  * E-mail: kakimi@m.u-tokyo.ac.jp

  Affiliation Department of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan

  ⨯